Neurogene Inc. (NGNE)
$39.64+2.61%Close
BUYRECOVERY · day 11
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $626M
- Avg volume
- 206.0K
- Beta
- 1.95
- P/E (TTM)
- -7.19
- Short % float
- 23.97%
- Days to cover
- 16.1
- SI change
- +2.6%
- 1W
- +8.07%
- 1M
- +13.58%
- 3M
- +43.05%
- YTD
- +96.63%
- vs SPY 1W
- +9.26%
- vs SPY 1M
- +10.26%
- vs SPY 3M
- +40.66%
- vs SPY YTD
- +84.87%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- ANIXBUYAnixa Biosciences, Inc.RECOVERYQ 6$3.62-2.43%
- ANROBUYAlto Neuroscience, Inc.BULLQ 27$36.25+5.75%
- CRBPBUYCorbus Pharmaceuticals Holdings, Inc.RECOVERYQ 6$10.69+2.99%
- CRDLBUYCardiol Therapeutics Inc.RECOVERYQ 4$1.86+0.00%
- CTNMBUYContineum Therapeutics, Inc. Class A Common StockRECOVERYQ 13$16.63-3.26%
- NBPBUYNovaBridge BiosciencesRECOVERYQ -4$1.89-5.50%
- SGMTBUYSagimet Biosciences Inc.BULLQ 8$10.21-0.39%
- SLDBSELLSolid Biosciences Inc.RECOVERYQ -12$9.16-1.51%
- SMMTSELLSummit Therapeutics Inc.CRISISQ 16$12.73-3.27%
- ABVXSELLAbivax S.A.BEARQ 61$116.15+1.04%
- ANNXSELLAnnexon, Inc.RECOVERYQ -7$5.06-0.20%
- CABABUYCabaletta Bio, Inc.RECOVERYQ -3$3.10-0.96%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 18
- VALUE
- 7
- GROWTH
- 47
- GARP
- 5
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-27.1%
REV YoY-
ROE-45.1%
EPS YoY-
ROA-45.5%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-7.19
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B4.12
P/FCF-
EV/EBITDA-4.91
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E3.84
ALTMAN Z-
CURR RATIO10.64
ND/EBITDA-
BETA1.95
